Finance & Shareholders
NEWS
----------------------------------------------------------------------
Further rise in earnings for S1 2011 :Solid perspectives
The healthy state of affairs for the business throughout all ORAPI zones, combined with the integration of the latest acquisitions (CREST and PHEM), enabled the Group to record, for the first half of 2011, a turnover figure of €63.55M, up 10.7% over S1 2010.
----------------------------------------------------------------------
|
|
|
A new eco-technology : BIOLOGICAL TREATMENT |
|
|
|
Chiffre d’affaires premier trimestre 2013 : 53,6 M€ (April 15, 2013)
|
Annual report 2010.